Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes

Detalhes bibliográficos
Autor(a) principal: Duarte,Fernando Barroso
Data de Publicação: 2016
Outros Autores: Santos,Talyta Ellen de Jesus dos, Barbosa,Maritza Cavalcante, Kaufman,Jacques, Vasconcelos,João Paulo de, Lemes,Romélia Pinheiro Gonçalves, Rocha,Francisco Dário, Coutinho,Diego Ferreira, Zalcberg,Ilana, Vasconcelos,Paulo Roberto Leitão de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025
Resumo: ABSTRACT The hematopoietic stem cell transplantation (HSCT) is the only curative alternative for Myelodysplastic Syndrome (MDS), but many patients are not eligible for this treatment, as there are several limiting factors, especially in the case of patients with low-risk MDS. The aim of this study is to discuss the factors that can guide the decision-making on referring or not a patient to HSCT. Three cases of MDS, two of which were submitted to HSCT are presented. We intend to report the difficulties in referring patients with MDS to transplant and the prognostic factors that contribute to define eligibility.
id AMB-1_bb5c21494c43202ea476f109998134b0
oai_identifier_str oai:scielo:S0104-42302016001200025
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic SyndromesMyelodysplastic SyndromeHematopoietic Stem Cell TransplantationPrognosisABSTRACT The hematopoietic stem cell transplantation (HSCT) is the only curative alternative for Myelodysplastic Syndrome (MDS), but many patients are not eligible for this treatment, as there are several limiting factors, especially in the case of patients with low-risk MDS. The aim of this study is to discuss the factors that can guide the decision-making on referring or not a patient to HSCT. Three cases of MDS, two of which were submitted to HSCT are presented. We intend to report the difficulties in referring patients with MDS to transplant and the prognostic factors that contribute to define eligibility.Associação Médica Brasileira2016-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025Revista da Associação Médica Brasileira v.62 suppl.1 2016reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.62.suppl1.25info:eu-repo/semantics/openAccessDuarte,Fernando BarrosoSantos,Talyta Ellen de Jesus dosBarbosa,Maritza CavalcanteKaufman,JacquesVasconcelos,João Paulo deLemes,Romélia Pinheiro GonçalvesRocha,Francisco DárioCoutinho,Diego FerreiraZalcberg,IlanaVasconcelos,Paulo Roberto Leitão deeng2016-12-01T00:00:00Zoai:scielo:S0104-42302016001200025Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2016-12-01T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
title Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
spellingShingle Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
Duarte,Fernando Barroso
Myelodysplastic Syndrome
Hematopoietic Stem Cell Transplantation
Prognosis
title_short Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
title_full Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
title_fullStr Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
title_full_unstemmed Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
title_sort Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
author Duarte,Fernando Barroso
author_facet Duarte,Fernando Barroso
Santos,Talyta Ellen de Jesus dos
Barbosa,Maritza Cavalcante
Kaufman,Jacques
Vasconcelos,João Paulo de
Lemes,Romélia Pinheiro Gonçalves
Rocha,Francisco Dário
Coutinho,Diego Ferreira
Zalcberg,Ilana
Vasconcelos,Paulo Roberto Leitão de
author_role author
author2 Santos,Talyta Ellen de Jesus dos
Barbosa,Maritza Cavalcante
Kaufman,Jacques
Vasconcelos,João Paulo de
Lemes,Romélia Pinheiro Gonçalves
Rocha,Francisco Dário
Coutinho,Diego Ferreira
Zalcberg,Ilana
Vasconcelos,Paulo Roberto Leitão de
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Duarte,Fernando Barroso
Santos,Talyta Ellen de Jesus dos
Barbosa,Maritza Cavalcante
Kaufman,Jacques
Vasconcelos,João Paulo de
Lemes,Romélia Pinheiro Gonçalves
Rocha,Francisco Dário
Coutinho,Diego Ferreira
Zalcberg,Ilana
Vasconcelos,Paulo Roberto Leitão de
dc.subject.por.fl_str_mv Myelodysplastic Syndrome
Hematopoietic Stem Cell Transplantation
Prognosis
topic Myelodysplastic Syndrome
Hematopoietic Stem Cell Transplantation
Prognosis
description ABSTRACT The hematopoietic stem cell transplantation (HSCT) is the only curative alternative for Myelodysplastic Syndrome (MDS), but many patients are not eligible for this treatment, as there are several limiting factors, especially in the case of patients with low-risk MDS. The aim of this study is to discuss the factors that can guide the decision-making on referring or not a patient to HSCT. Three cases of MDS, two of which were submitted to HSCT are presented. We intend to report the difficulties in referring patients with MDS to transplant and the prognostic factors that contribute to define eligibility.
publishDate 2016
dc.date.none.fl_str_mv 2016-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016001200025
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.62.suppl1.25
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.62 suppl.1 2016
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212832343228416